Our latest News & Events
The French Repository for Generic medicinal Products
What’s the French Repository of Generic Medicinal products ? According to European regulation, ‘Generic medicinal product’ shall mean a medicinal product which has the same
What is an EU RMP ?
A Risk Management Plan (RMP) is an essential element of pharmacovigilance activities. Its primary objective is to identify, characterize, and minimize the risks associated with
ICH and its influence on global regulation
Presentation of ICH (roles, history, missions, etc.) ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) is an organisation that brings together
Paediatric Investigation Plans & paediatric requirements in the EU
The need for a paediatric regulation for medicines The need for a paediatric regulation in the EU is born almost 30 years ago with the
Atessia takes a strategic leap with the integration of AnticipSanté
This merger enriches our service offering and affirms our commitment to supporting healthcare players in meeting the regulatory and operational challenges of today and tomorrow.
ATESSIA, Your Guide to Efficient Regulatory Affairs in the Pharma Industry
In the intricate and highly regulated world of pharmaceuticals and healthcare, ATESSIA stands out as a consulting firm dedicated to guiding companies through the complexities
ATESSIA Named Among the “5 Best Pharma Consulting Companies to Watch in 2024”
We are proud to be featured in The Silicon Review, a recognition that highlights our unwavering commitment to excellence in regulatory affairs. In the pharmaceutical
Forbes – ATESSIA, Life Science Advisors : The Regulatory and Pharmaceutical Affairs Consulting Firm Dedicated to the Healthcare Industry
Leveraging its expertise, ATESSIA supports a wide range of health products, with a particular focus on pharmaceuticals and medical devices. Through a tailored and rigorous
Understanding EUDAMED: The European Database on Medical Devices
The new regulation (EU) 2017/745 introduces new requirements to enhance the safety of patients and users. One of the novelties of this new regulation is